BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38336561)

  • 1. Leveraging the immunoinformatics approach for designing the SARS-CoV-2 omicron-specific antigenic cassette of mRNA vaccine.
    Wadapurkar R; Singh S; Singh A
    Vaccine; 2024 Mar; 42(7):1630-1647. PubMed ID: 38336561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach.
    Bhattacharya M; Sharma AR; Ghosh P; Patra P; Patra BC; Lee SS; Chakraborty C
    Mol Biotechnol; 2022 May; 64(5):510-525. PubMed ID: 34981440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico SARS-CoV-2 vaccine development for Omicron strain using reverse vaccinology.
    Li V; Lee C; Yoo D; Cho S; Kim H
    Genes Genomics; 2022 Aug; 44(8):937-944. PubMed ID: 35665465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach.
    Ahammad I; Lira SS
    Int J Biol Macromol; 2020 Nov; 162():820-837. PubMed ID: 32599237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
    Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
    Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
    Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
    Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
    Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
    Front Immunol; 2021; 12():692937. PubMed ID: 34497604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches.
    Yu M; Zhu Y; Li Y; Chen Z; Li Z; Wang J; Li Z; Zhang F; Ding J
    Front Immunol; 2022; 13():884433. PubMed ID: 35603198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
    Jakhar R; Kaushik S; Gakhar SK
    J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
    Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C
    J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach.
    Samad A; Ahammad F; Nain Z; Alam R; Imon RR; Hasan M; Rahman MS
    J Biomol Struct Dyn; 2022 Jan; 40(1):14-30. PubMed ID: 32677533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
    Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
    Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a multi-epitope-based vaccine consisted of immunodominant epitopes of structural proteins of SARS-CoV-2 using immunoinformatics approach.
    Mahmoudvand S; Esmaeili Gouvarchin Ghaleh H; Jalilian FA; Farzanehpour M; Dorostkar R
    Biotechnol Appl Biochem; 2023 Jun; 70(3):1189-1205. PubMed ID: 36577011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excavating SARS-coronavirus 2 genome for epitope-based subunit vaccine synthesis using immunoinformatics approach.
    Chauhan V; Rungta T; Rawat M; Goyal K; Gupta Y; Singh MP
    J Cell Physiol; 2021 Feb; 236(2):1131-1147. PubMed ID: 32643158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants.
    Campos DMO; Silva MKD; Barbosa ED; Leow CY; Fulco UL; Oliveira JIN
    Comput Biol Chem; 2022 Dec; 101():107754. PubMed ID: 36037724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach.
    Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M
    Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
    Tahir Ul Qamar M; Rehman A; Tusleem K; Ashfaq UA; Qasim M; Zhu X; Fatima I; Shahid F; Chen LL
    PLoS One; 2020; 15(12):e0244176. PubMed ID: 33351863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
    Chand Y; Singh S
    Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy.
    Ezaj MMA; Junaid M; Akter Y; Nahrin A; Siddika A; Afrose SS; Nayeem SMA; Haque MS; Moni MA; Hosen SMZ
    J Biomol Struct Dyn; 2022 Sep; 40(14):6477-6502. PubMed ID: 33586620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.